Avatar-based Mobile Phone Intervention for Medication Adherence and Retention in Care
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a mobile phone app designed to help African American men who have sex with men (AAMSM) manage their HIV treatment more effectively. The app features a talking avatar that provides support and information about medication adherence and maintaining doctor visits. The researchers aim to determine if this app offers more benefits than a standard app focused on food safety, such as "My Personal Food Guide" or "My Personal Health Guide." AAMSM who own a smartphone and have experienced difficulty adhering to HIV medication or attending doctor visits may be well-suited for this trial.
As an unphased trial, this study presents a unique opportunity to contribute to innovative research that could improve HIV treatment management for AAMSM.
Do I have to stop taking my current medications for this trial?
The trial does not specify if you need to stop taking your current medications. It seems to focus on helping you stick to your HIV treatment, so you likely won't need to stop your current meds.
What prior data suggests that this mobile phone intervention is safe for users?
Research shows that the avatar-based mobile phone app helps people follow their HIV treatment plan. A talking avatar provides information and encouragement. Studies have found that similar digital tools can make users feel comfortable, helping them discuss their health without awkwardness.
No reports of risks or side effects have emerged from using this type of app. Since it mainly provides information and motivation through a phone, it appears to be a safe support tool for managing HIV care.12345Why are researchers excited about this trial?
Researchers are excited about the avatar-based mobile phone intervention for medication adherence and retention in HIV care because it offers a novel way to engage patients. Unlike traditional methods, which often rely on direct healthcare provider interaction, this app uses a realistic talking human avatar to promote adherence to antiretroviral therapy (ART) and retention in care. This innovative approach leverages technology to motivate and provide personalized information, potentially enhancing patient engagement and improving health outcomes. Additionally, the app's ability to deliver behavioral skills training directly to a mobile device makes it a convenient and accessible option for users.
What evidence suggests that the Avatar intervention app is effective for improving medication adherence and retention in care for HIV-positive individuals?
Research has shown that the "My Personal Health Guide" app, featuring a talking avatar, can help people adhere to their HIV treatment and remain in care. In this trial, participants in the experimental arm will use the Avatar intervention app, which includes a lifelike talking avatar to enhance adherence to antiretroviral therapy (ART) by providing motivation and key information. The app makes HIV care more private and convenient, addressing challenges like stigma and low health literacy. Early results suggest that regular use of the app's motivational messages may improve medication adherence. This app aims to make managing HIV treatment easier and more engaging for users.12367
Who Is on the Research Team?
Mark Dworkin, MD
Principal Investigator
University of Illinois at Chicago
Are You a Good Fit for This Trial?
This trial is for African American men who have sex with men (AAMSM), aged 18-34, who own smartphones and are prescribed antiretroviral therapy (ART). They must either be starting ART or already on it, have a detectable viral load in the past month, or have adherence issues. Those who can't participate include non-English speakers, those without upcoming clinic appointments, or anyone involved in earlier app testing phases.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Monitoring
Baseline ART adherence is monitored wirelessly for 1 month
Intervention
Participants use the My Personal Health Guide Avatar application or control app for adherence and retention in care
Follow-up
Participants are monitored for ART adherence, viral load, and retention in care
What Are the Treatments Tested in This Trial?
Interventions
- My Personal Food Guide
- My Personal Health Guide
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor
Ruth M. Rothstein CORE Center
Collaborator
Emory University
Collaborator
National Institute of Mental Health (NIMH)
Collaborator
University of Mississippi Medical Center
Collaborator